U.S. flag

An official website of the United States government

NM_000153.4(GALC):c.673G>A (p.Ala225Thr) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Nov 3, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001508371.4

Allele description [Variation Report for NM_000153.4(GALC):c.673G>A (p.Ala225Thr)]

NM_000153.4(GALC):c.673G>A (p.Ala225Thr)

Gene:
GALC:galactosylceramidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q31.3
Genomic location:
Preferred name:
NM_000153.4(GALC):c.673G>A (p.Ala225Thr)
HGVS:
  • NC_000014.9:g.87976437C>T
  • NG_011853.3:g.22127G>A
  • NM_000153.4:c.673G>AMANE SELECT
  • NM_001201401.2:c.604G>A
  • NM_001201402.2:c.595G>A
  • NP_000144.2:p.Ala225Thr
  • NP_001188330.1:p.Ala202Thr
  • NP_001188331.1:p.Ala199Thr
  • NC_000014.8:g.88442781C>T
  • NG_011853.2:g.22127G>A
  • NM_000153.3:c.673G>A
  • p.Ala225Thr
Protein change:
A199T
Links:
dbSNP: rs1436074042
NCBI 1000 Genomes Browser:
rs1436074042
Molecular consequence:
  • NM_000153.4:c.673G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001201401.2:c.604G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001201402.2:c.595G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001714489Mayo Clinic Laboratories, Mayo Clinic
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Nov 3, 2019)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot providednot providednot providedclinical testing

Citations

PubMed

Newborn screening for Krabbe disease in New York State: the first eight years' experience.

Orsini JJ, Kay DM, Saavedra-Matiz CA, Wenger DA, Duffner PK, Erbe RW, Biski C, Martin M, Krein LM, Nichols M, Kurtzberg J, Escolar ML, Adams DJ, Arnold GL, Iglesias A, Galvin-Parton P, Kronn DF, Kwon JM, Levy PA, Pellegrino JE, Shur N, Wasserstein MP, et al.

Genet Med. 2016 Mar;18(3):239-48. doi: 10.1038/gim.2015.211. Epub 2016 Jan 21.

PubMed [citation]
PMID:
26795590

Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe's disease.

Saavedra-Matiz CA, Luzi P, Nichols M, Orsini JJ, Caggana M, Wenger DA.

J Neurosci Res. 2016 Nov;94(11):1076-83. doi: 10.1002/jnr.23905.

PubMed [citation]
PMID:
27638593
See all PubMed Citations (3)

Details of each submission

From Mayo Clinic Laboratories, Mayo Clinic, SCV001714489.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (3)

Description

PS3, PM2, PM5

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024